PATENT CLAIM ANALYSIS

Application Number: 16277689
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "045000"]

Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.

Claim (Index 1):
A method of treating chronic cough in a subject having idiopathic pulmonary fibrosis, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising cromolyn, or a pharmaceutically acceptable salt thereof, with an inhalation device, wherein the subject has been diagnosed as having idiopathic pulmonary fibrosis prior to administration of the pharmaceutical composition, and wherein the pharmaceutical composition is not administered to the subject if the subject has been diagnosed as having chronic idiopathic cough.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15887830', '15750811', '15750809', '14686535', '16273987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7754512269947554
- 35 USC 102 Novelty (BERT): 0.6620865842708838
- Combined Prediction Score: 0.7641147627223682
- Mean Citation Score: 431.317602
- Max Citation Score: 721.60675
- Similarity Product: 602.8651933766306

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test